Have you taken Actos to treat Type 2 diabetes? Studies have shown an increased risk of bladder cancer after taking Actos.
If you have taken Actos and have developed bladder cancer, you may have a claim. At the Pittsburgh office of Robert Peirce & Associates, P.C., we have brought lawsuits on behalf of clients injured as a result of taking Actos.
Link Between Actos and Bladder Cancer
Pioglitazone, branded as Actos in the United States, is used to treat Type 2 diabetes. It was approved in 1999 by the FDA and distributed in the U.S. by Takeda Pharmaceuticals and Eli Lilly and Company. It is available as oral tablets in a range of doses.
In 2011, the FDA issued a safety warning about Actos. The FDA warned that use of Actos for more than one year may be associated with an increased risk of bladder cancer. That same year, Takeda issued a recall of the drug in France. The drug has not been recalled in the U.S.
Actos Side Effects Lawyers in Pennsylvania Serving Clients Nationwide
If you have developed bladder cancer after taking Actos, we can help you bring a claim against Takeda and Eli Lilly for failing to warn patients, physicians and medical professionals about Actos risks. To speak with an attorney, contact our office online or call us at 866-273-1941 to schedule an appointment.